Tectonic Therapeutic, Inc. (NASDAQ:TECX) — Market Cap & Net Worth
Market Cap & Net Worth: Tectonic Therapeutic, Inc. (TECX)
Tectonic Therapeutic, Inc. (NASDAQ:TECX) has a market capitalization of $545.65 Million ($545.65 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #12071 globally and #2847 in its home market, demonstrating a 2.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tectonic Therapeutic, Inc.'s stock price $29.06 by its total outstanding shares 18776626 (18.78 Million). Analyse Tectonic Therapeutic, Inc. cash conversion from operations to see how efficiently the company converts income to cash.
Tectonic Therapeutic, Inc. Market Cap History: 2018 to 2026
Tectonic Therapeutic, Inc.'s market capitalization history from 2018 to 2026. Data shows growth from $15.02K to $545.65 Million (250.79% CAGR).
Index Memberships
Tectonic Therapeutic, Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.02% | #309 of 976 |
Weight: Tectonic Therapeutic, Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tectonic Therapeutic, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tectonic Therapeutic, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TECX by Market Capitalization
Companies near Tectonic Therapeutic, Inc. in the global market cap rankings as of May 4, 2026.
Key companies related to Tectonic Therapeutic, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Tectonic Therapeutic, Inc. Historical Marketcap From 2018 to 2026
Between 2018 and today, Tectonic Therapeutic, Inc.'s market cap moved from $15.02K to $ 545.65 Million, with a yearly change of 250.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $545.65 Million | +39.31% |
| 2025 | $391.68 Million | -54.82% |
| 2024 | $866.92 Million | +5771150.00% |
| 2023 | $15.02K | -84.00% |
| 2022 | $93.88K | +127.27% |
| 2021 | $41.31K | +214.29% |
| 2020 | $13.14K | -30.00% |
| 2019 | $18.78K | +25.00% |
| 2018 | $15.02K | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Tectonic Therapeutic, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $545.65 Million USD |
| MoneyControl | $545.65 Million USD |
| MarketWatch | $545.65 Million USD |
| marketcap.company | $545.65 Million USD |
| Reuters | $545.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RX… Read more